Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1093458


Cardiac Markers Pipeline Technology and Market Forecasts to 2015


Description: “Cardiac Markers Pipeline Technology and Market Forecasts to 2015” report is an essential source of information and analysis on the global cardiac markers market. The report identifies the key trends shaping and driving the dynamism in the global cardiac markers market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cardiac markers sector.

Scope

- This report analyzes a key segment within the in vitro diagnostics market with focus on the cardiovascular segment
- Annualized global cardiac markers market revenues data from 2001 to 2008, forecast forward for 7 years to 2015. Updated company shares data for 2008.
- Analysis and review of the key events and milestones that will impact the future of the global cardiac markers market. Each trend independently researched to provide qualitative analysis of what the implications on sectors are, and how are companies responding to these trends.
- Insightful review of key industry drivers, restraints and challenges which are likely to impact the global cardiac markers market in the long run.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.Key companies covered include Abbott, Roche Diagnostics and Siemens Medical
- Comprehensive analysis of the most likely developments expected to bring a shift to the market positions of the leading manufacturers.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global cardiac markers market.
- Identify key players best positioned to take advantage of the emerging market opportunities by developing insight on the prevalent and anticipated competitive landscape.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global cardiac markers market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- Support your go/non-go dilemma by identifying the markets that are least competitive and present significant opportunities for innovation and growth.
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.


Contents: 1 Table Of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures

2 Cardiac Markers Pipeline Technology and Market Forecasts to 2015
2.1 Executive Summary

3 Cardiac Markers Technology Landscape
3.1 Cardiac Markers: Overview
3.2 Disease Background
3.3 Cardiac Markers Clinical Trials
3.3.1 Circulating Markers that Underlie the Transition from Compensated Hypertrophy to Heart Failure
3.3.2 Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study (LE-Heart)
3.3.3 Discovery of New Circulating Biomarkers of Coronary Atherosclerosis
3.3.4 Assessment of New Biomarkers in the Management and Triage of Patients with Chest Pain and Suspicion of Non ST Elevation Acute Coronary Syndrome

4 Global Cardiac Markers Market
4.1 Market Overview
4.2 Cardiac Markers Market Dynamics
4.2.1 Market Drivers
4.2.1.1 Increasing Incidence of Cardiovascular Diseases Will Drive the Cardiac Markers Market
4.2.1.2 Increasing Awareness of Early Screening, Detection and Diagnosis Fuelling Growth
4.2.1.3 Point of Care (POC) Technologies will Drive Growth
4.2.2 Market Restraints
4.2.2.1 Low Reimbursement Rates will Hamper Growth
4.2.3 Technology Trends
4.2.4 Cross Country Comparison

5 Cardiac Markers Competitive Landscape
5.1 Abbott
5.2 Roche Diagnostics
5.3 Siemens Medical
5.4 Others

6 Cardiac Markers Pipeline Products
6.1 ARCHITECT MPO Assay
6.1.1 Product Status
6.1.2 Product Description
6.1.3 Clinical Trial
6.2 Next Generation Triage CardioProfilER
6.2.1 Product Status
6.2.2 Product Description
6.3 SYNCHRON Anti-Cardiolipin test
6.3.1 Product Status
6.3.2 Product Description
6.4 Vyent NT-proBNP
6.4.1 Product Status
6.4.2 Product Description
6.4.3 Clinical Trial
6.5 CADPrint
6.5.1 Product Status
6.5.2 Product Description
6.5.3 Clinical Trial
6.6 Key Takeaway

7 Appendix
7.1 Definitions
7.1.1 Cardiac Markers
7.2 Research Methodology
7.3 Secondary Research
7.4 Primary Research
7.5 Models
7.6 Forecasts
7.7 Expert Panels
7.8 GlobalData Consulting
7.9 Contact Us
7.10 Disclaimer

List of Tables

Table 1: Commonly Used Cardiac Markers, Indications and Reference Range
Table 2: Cardiovascular Disease Statistics, US, 2006
Table 3: Cardiac Markers, Global, Revenue ($ m), 2000-2008
Table 4: Cardiac Markers, Global, Revenue ($ m), 2008-2015
Table 5: Novel Cardiac Markers Under Study
Table 6: Cardiac Markers, Cross Country Comparison of Revenue – 2008 and 2015
Table 7: Cardiac Markers Pipeline Products by Development Stage
Table 8: ARCHITECT MPO Assay, Product Status
Table 9: ARCHITECT MPO Assay, Product Description
Table 10: Architect MPO Assay Clinical Trial
Table 11: Next Generation Triage CardioProfilER, Product Status
Table 12: Next Generation Triage CardioProfilER, Product Description
Table 13: SYNCHRON Anti-Cardiolipin test, Product Status
Table 14: SYNCHRON Anti-Cardiolipin test, Product Description
Table 15: Vyent NT-proBNP, Product Status
Table 16: Vyent NT-proBNP, Product Description
Table 17: Vyent NT-proBNP, Clinical Trial
Table 18: CADPrint, Product Status
Table 19: CADPrint, Product Description
Table 20: CADPrint, Clinical Trial
Table 21: Global Cardiac Markers Pipeline Products Summary




Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1093458

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 01:28:30
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Cardiac Markers Pipeline Technology and Market Forecasts to 2015
Web Address:
http://www.researchandmarkets.com/reports/1093458
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €1,529.00
Electronic (PDF) - Site License €3,057.00
Electronic (PDF) - Enterprisewide €4,586.00



Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 01:28:30

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)